- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- March 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- March 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 372 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 374 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 273 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 183 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 474 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 291 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 159 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 194 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 269 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- March 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more